BridgeBio Pharma, Inc. (BBIO) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $936.02M | +1.8% |
| 2024 | $919.34M | +68.3% |
| 2023 | $546.38M | -12.3% |
| 2022 | $623.04M | -38.5% |
| 2021 | $1.01B | +43.9% |
| 2020 | $703.59M | +11.4% |
| 2019 | $631.68M | +35.9% |
| 2018 | $464.94M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $936.02M | +1.8% |
| 2024 | $919.34M | +68.3% |
| 2023 | $546.38M | -12.3% |
| 2022 | $623.04M | -38.5% |
| 2021 | $1.01B | +43.9% |
| 2020 | $703.59M | +11.4% |
| 2019 | $631.68M | +35.9% |
| 2018 | $464.94M | — |